The aim of the project is the introduction of a new product and new production technology by AS “Olainfarm” by developing a production line (experimental technology). The project implementation period is planned from 24 May 2017 until 23 August 2019 (27 months). The total planned eligible project costs are EUR 6 373 939.83, ERDF support EUR 2 230 878.93The project is planned to be implemented in the pharmaceutical industry NACE code C 21.20 Manufacture of pharmaceutical preparations and NACE code C 21.10 Production of basic pharmaceuticals.The project will create a pilot production line with the supporting laboratory equipment for a new finished pharmaceutical form (capsule/tablet (250 mg)), which is a second-line anti-tuberculosis treatment agent that is used for the treatment of TB. Experimental production line will also be used in research of other new products – product development, technology scaling, pilot series production and potentially also production depending on interoperability of technological processes, production volumes and load of equipment.